NEWPORT PHARMACEUTICALS SUBMITTING ADDITIONAL STUDIES TO ISOPRINOSINE NDA FOR AIDS-RELATED COMPLEX; TRIALS WILL INCLUDE 200 PATIENTS FROM U.S.